Your browser doesn't support javascript.
loading
CD47: Beyond an immune checkpoint in cancer treatment.
Bian, Hui-Ting; Shen, Yi-Wen; Zhou, Yu-Dong; Nagle, Dale G; Guan, Ying-Yun; Zhang, Wei-Dong; Luan, Xin.
Afiliação
  • Bian HT; Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Shen YW; Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Zhou YD; Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Department of Chemistry and Biochemistry, College of Liberal Arts, University of Mississ
  • Nagle DG; Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Department of BioMolecular Sciences and Research Institute of Pharmaceutical Sciences, S
  • Guan YY; Department of Pharmacy, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China. Electronic address: gyy40696@rjh.com.cn.
  • Zhang WD; Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: wdzhangy@hotmail.com.
  • Luan X; Shanghai Frontiers Science Center for Chinese Medicine Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: luanxin@shutcm.edu.cn.
Biochim Biophys Acta Rev Cancer ; 1877(5): 188771, 2022 09.
Article em En | MEDLINE | ID: mdl-35931392

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno CD47 / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Biochim Biophys Acta Rev Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno CD47 / Neoplasias Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Biochim Biophys Acta Rev Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China